{"transactions":[{"id":1113592,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T16:50:13.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000065","document":"wk-form4_1749761408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169025000065/wk-form4_1749761408.xml","form_type":"4"}},{"id":1473312,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:22:31.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000032","document":"wk-form4_1718914944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169024000032/wk-form4_1718914944.xml","form_type":"4"}},{"id":1852489,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:17:02.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000058","document":"wf-form4_168694661088294.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169023000058/wf-form4_168694661088294.xml","form_type":"4"}},{"id":1856012,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T18:32:35.000Z","date":"2023-06-13","kind":"purchase","planned":false,"acquired":true,"shares":65789,"price":0.76,"value":49999.64,"ownership":{"direct":true},"balance_after":65789,"source":{"system":"sec-edgar","filing":"0001411690-23-000034","document":"wf-form4_168678194063640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169023000034/wf-form4_168678194063640.xml","form_type":"4"}},{"id":2206343,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-18T19:25:46.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":44470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029."}],"balance_after":44470,"derivative":{"exercise_price":0.51,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":44470},"source":{"system":"sec-edgar","filing":"0001209191-22-042480","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000120919122042480/doc4a.xml","form_type":"4/A","original_submission_date":"2020-07-02"}},{"id":2234275,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T16:32:18.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":164422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":164422,"derivative":{"exercise_price":1.62,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":164422},"source":{"system":"sec-edgar","filing":"0001209191-22-036328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000120919122036328/doc4.xml","form_type":"4"}},{"id":2596311,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-19T17:20:31.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":40751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":40751,"derivative":{"exercise_price":5.34,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":40751},"source":{"system":"sec-edgar","filing":"0001209191-21-052586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000120919121052586/doc4.xml","form_type":"4"}},{"id":2670371,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T19:16:03.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":7528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":7528,"derivative":{"exercise_price":7.64,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":7528},"source":{"system":"sec-edgar","filing":"0001209191-21-040404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000120919121040404/doc4.xml","form_type":"4"}},{"id":3092457,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-02T20:31:15.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":44470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."}],"balance_after":44470,"derivative":{"exercise_price":0.51,"expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":44470},"source":{"system":"sec-edgar","filing":"0001209191-20-040759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000120919120040759/doc4.xml","form_type":"4"}},{"id":3159722,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-06T14:30:08.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":80923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."}],"balance_after":80923,"derivative":{"exercise_price":0.38,"expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":80923},"source":{"system":"sec-edgar","filing":"0001209191-20-027427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000120919120027427/doc4.xml","form_type":"4"}}]}